이상반응 보고
| VAERS ID | 1930254 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | 1 |
| 접종일 | 2021-07-30 |
| 발병일 | 2021-07-31 |
| 상태 |
증상
- 두통(Headache)
- SARS-CoV-2 테스트(SARS-CoV-2 test)
- 자궁 출혈(Uterine haemorrhage)
이환 중 질병
지병
Medical History/Concurrent Conditions: Endometriosis
기타 의료
이전 예방접종
알레르기
임상 검사
Test Date: 20210819; Test Name: SARS-CoV-2 test; Result Unstructured Data: Test Result:Negative,
증상 상세
Uterine bleeding; Headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from the European Medicines Agency (EMA) EudraVigilance-WEB.
Regulatory number: FR-AFSSAPS-ST20214340 (AFSSAPS).
A 33 year-old female patient received bnt162b2 (COMIRNATY), intramuscular, administration date 30Jul2021 (Lot number: unknown) as dose 1, 0.
3ml single for covid-19 immunisation.
Relevant medical history included: "Endometriosis" (unspecified if ongoing).
The patient's concomitant medications were not reported.
The following information was reported: UTERINE HAEMORRHAGE (medically significant) with onset 31Jul2021, outcome "not recovered", described as "Uterine bleeding"; HEADACHE (non-serious) with onset 31Jul2021, outcome "not recovered", described as "Headache".
The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (19Aug2021) negative.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.